Phase I study on the sequential administration of recombinant human interferon-gamma and recombinant human interleukin-2 in patients with metastatic solid tumors

J Natl Cancer Inst. 1991 Oct 2;83(19):1408-10. doi: 10.1093/jnci/83.19.1408.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Humans
  • Interferon-gamma / administration & dosage
  • Interferon-gamma / adverse effects
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / adverse effects
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasms / drug therapy*
  • Recombinant Proteins / administration & dosage

Substances

  • Interleukin-2
  • Recombinant Proteins
  • Interferon-gamma